Invesco Nasdaq Biotechnology ETF Rating → [Urgent] Your ESG score is here (From Weiss Ratings) (Ad) Free IBBQ Stock Alerts $22.20 -0.19 (-0.85%) (As of 03:26 PM ET) Add Compare Share Share RatingsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends Invesco Nasdaq Biotechnology ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBBQ Aggregate RatingModerate Buy2.59Holdings in IBBQ have an aggregate rating of Moderate Buy based on 664 analyst ratings issued in the past year covering 50 companies (82.2% of the portfolio).IBBQ Aggregate Price Target$26.0617.37% UpsideHigh Prediction$34.48Average Prediction$26.06Low Prediction$18.69Holdings in IBBQ have an aggregate price target of $26.06 and a range of $18.69 to $34.48 covering 50 companies (82.2% of the portfolio).IBBQ Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy33 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell1 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Nasdaq Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 IBBQ Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.23%VRTXVertex Pharmaceuticals$468.44-1.1%4 of 5 stars2.52$443.55 -5.3%25Analyst Forecast8.96%AMGNAmgen$305.97+0.9%5 of 5 stars2.52$305.85 0.0%21Short Interest ↓8.35%REGNRegeneron Pharmaceuticals$1,037.80-0.7%4 of 5 stars2.77$998.09 -3.8%22Analyst ForecastInsider Selling7.22%GILDGilead Sciences$62.76-2.3%5 of 5 stars2.35$83.69 33.3%17Short Interest ↑5.92%MRNAModerna$133.68-3.1%4 of 5 stars2.24$129.02 -3.5%174.79%AZNAstraZeneca$78.44-1.1%3 of 5 stars2.67$88.00 12.2%9Short Interest ↓3.36%BIIBBiogen$223.82-1.2%5 of 5 stars2.65$286.50 28.0%26Short Interest ↓1.98%ALNYAlnylam Pharmaceuticals$153.57-2.4%5 of 5 stars2.59$216.19 40.8%17Options VolumePositive News1.86%ILMNIllumina$106.89-2.0%5 of 5 stars2.29$158.14 47.9%21Gap Up1.57%BMRNBioMarin Pharmaceutical$84.90-0.1%5 of 5 stars2.57$106.11 25.0%21Short Interest ↓Positive News1.38%SNYSanofi$47.25-0.1%2 of 5 stars2.40$55.00 16.4%5Positive News1.38%NBIXNeurocrine Biosciences$131.85-2.5%5 of 5 stars2.80$152.00 15.3%25Positive News1.36%INCYIncyte$61.45-2.0%5 of 5 stars2.44$73.69 19.9%18Analyst Forecast1.33%UTHRUnited Therapeutics$306.00+3.0%4 of 5 stars2.90$312.22 2.0%10Insider Selling1.28%VTRSViatris$10.05-0.6%1 of 5 stars1.33$11.00 9.5%3Insider Selling1.27%MEDPMedpace$399.50+0.9%5 of 5 stars2.86$443.14 10.9%7Positive News1.26%RPRXRoyalty Pharma$26.16-1.7%5 of 5 stars2.80$43.00 64.4%5Positive News1.20%ARGXargenx$382.69+1.2%3 of 5 stars2.80$520.68 36.1%20Analyst ForecastAnalyst Revision1.19%SRPTSarepta Therapeutics$118.16+1.1%5 of 5 stars2.80$164.00 38.8%15Positive News1.00%BNTXBioNTech$85.68-3.1%3 of 5 stars2.20$111.70 30.4%10Short Interest ↓0.87%ROIVRoivant Sciences$10.78+0.6%2 of 5 stars2.90$16.90 56.8%10Analyst ForecastPositive News0.87%INSMInsmed$65.34+1.0%3 of 5 stars3.00$59.25 -9.3%160.81%ASNDAscendis Pharma A/S$124.13-0.4%3 of 5 stars2.89$179.44 44.6%9Positive News0.79%PCVXVaxcyte$71.63-0.3%0 of 5 stars3.00$78.50 9.6%4Positive News0.72%JAZZJazz Pharmaceuticals$113.47-0.9%5 of 5 stars2.86$190.92 68.3%14Positive News0.68%RVMDRevolution Medicines$37.56+1.2%4 of 5 stars3.10$43.20 15.0%10Positive News0.68%ITCIIntra-Cellular Therapies$75.69+9.9%4 of 5 stars2.91$91.50 20.9%11Analyst ForecastShort Interest ↓News CoveragePositive NewsGap UpHigh Trading Volume0.68%EXELExelixis$21.58-0.9%5 of 5 stars2.59$26.13 21.1%17Positive News0.67%BGNEBeiGene$153.97-3.4%2 of 5 stars2.80$251.93 63.6%10Short Interest ↓Positive News0.66%HALOHalozyme Therapeutics$50.79+2.3%5 of 5 stars2.75$54.13 6.6%8Gap Up0.65%BPMCBlueprint Medicines$106.24+2.3%1 of 5 stars2.63$108.00 1.7%160.59%IONSIonis Pharmaceuticals$40.58-0.4%4 of 5 stars2.67$58.43 44.0%15News CoveragePositive News0.56%SMMTSummit Therapeutics$8.00+1.3%3 of 5 stars3.00$13.50 68.8%2Positive News0.56%CYTKCytokinetics$51.76-1.9%4 of 5 stars2.82$76.41 47.6%17Analyst ForecastInsider SellingShort Interest ↑News Coverage0.50%MDGLMadrigal Pharmaceuticals$276.19-0.2%5 of 5 stars2.75$348.17 26.1%120.50%APLSApellis Pharmaceuticals$39.67-1.6%4 of 5 stars2.81$74.38 87.5%16Positive News0.49%BBIOBridgeBio Pharma$27.47+0.9%4 of 5 stars2.92$47.62 73.3%12Short Interest ↑0.48%KRYSKrystal Biotech$174.91-1.6%4 of 5 stars3.00$177.63 1.6%9Positive News0.48%NUVLNuvalent$78.20+1.3%1 of 5 stars2.90$90.78 16.1%10Positive News0.48%CRSPCRISPR Therapeutics$60.43-2.2%1 of 5 stars2.35$75.71 25.3%17Analyst Forecast0.42%IBRXImmunityBio$6.18+6.0%0 of 5 stars2.00$6.00 -2.9%10.41%ALKSAlkermes$24.61-1.6%5 of 5 stars2.55$36.50 48.3%11Analyst ForecastShort Interest ↓News CoveragePositive News0.37%LEGNLegend Biotech$40.33-2.8%2 of 5 stars3.00$81.67 102.5%13Analyst ForecastNews Coverage0.37%IMVTImmunovant$26.43-1.4%2 of 5 stars3.00$48.75 84.4%17Analyst ForecastPositive News0.36%GHGuardant Health$29.95-1.8%4 of 5 stars2.86$36.91 23.2%14Positive News0.36%AXSMAxsome Therapeutics$75.96-0.1%4 of 5 stars2.92$122.08 60.7%13Short Interest ↑Positive News0.35%RAREUltragenyx Pharmaceutical$37.37-6.1%4 of 5 stars2.93$86.71 132.0%14Analyst Revision0.32%CRNXCrinetics Pharmaceuticals$44.31-0.9%4 of 5 stars2.92$62.50 41.1%12Positive News0.32%MRUSMerus$54.04-3.1%3 of 5 stars3.00$73.60 36.2%12Analyst Forecast0.30%FOLDAmicus Therapeutics$9.80-2.4%4 of 5 stars2.88$17.57 79.3%8Positive News This page (NASDAQ:IBBQ) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredBiden out June 13; replacement chosen?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
